Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography

REFERENCES

• Bonfioli AA, Orefice F. Sarcoidosis. Sem in Ophthalmol 2007;20:177–82.
   Google Scholar
• Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society World Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149–173.
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA, Case Control Etiologic Study of Sarcoidosis (ACCESS) research group, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885–1889.
   PubMed Web of Science ®Google Scholar
• Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol 1992;36:452–457.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Azuma A, Abe S, Kawanami O, Ohara K, Kudoh S. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur Respir J 2001;18:515–521.
   PubMed Web of Science ®Google Scholar
• Jannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153–65.
   PubMed Web of Science ®Google Scholar
• Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center: Analysis of 1916 patients. J Rheumatol 2009;36:127–136.
   PubMed Web of Science ®Google Scholar
• Pietinalho A, Ohmichi M, Hiraga Y, et al. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: A comparative analyses of 571 Finish and 686 Japanese patients. Sarcoidosis 1996;13:159–166.
   Google Scholar
• Pietinalho A, Ohmichi M, Löfroos AB, Hiraga V, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan: A comparative five-year study of biopsy-proven cases. Sarcoidoses Vasc Diffuse Lung Dis 2000;17:158–166.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: Results of the First International Workshop. Am J Ophthalmol 2005;140:509–16.
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Hanada A, Horie S, Sugamoto Y, Sugita S, Mochizuki M. Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients. Jpn J Ophthalmol 2007;51:121–6.
   PubMed Web of Science ®Google Scholar
• Babu K, Kini R, Mehta R, Abraham MP, Subbakrishna DK, Murthy KR. Clinical profile of ocular sarcoidosis in a South Indian patient population. Ocul Immunol Inflamm 2010;18(5):362–9.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee HG, Kim DS, Kim JG, Ching H, Yoon YH. Ocular sarcoidosis in a Korean population. J Korean Med Sci 2009;24:413–9.
   PubMed Web of Science ®Google Scholar
• Evans M, Sharma O, LaBree I, Smith RE, Rao NA. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology 2007;114:325–33.
   PubMed Web of Science ®Google Scholar
• Pattishall EN, Strope GL, Spinola SM, Denny FW. Childhood sarcoidosis. J Pediatr 1986; 108:169–177.
   PubMed Web of Science ®Google Scholar
• Shetty AK, Gedalia A. Childhood sarcoidosis: A rare but fascinating disorder. J Pediatr Rheumatol Online J 2008;6:16.
   PubMedGoogle Scholar
• Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 1999;160:736–55.
   PubMed Web of Science ®Google Scholar
• Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 2009;17:160–9.
   PubMed Web of Science ®Google Scholar
• Ohara K, Judson MA, Baughman RP. Clinical aspects of ocular sarcoidosis. In: M. Drent, U. Costabel (eds.), Sarcoidosis, pp. 188–209. Wakefield, UK: Charlesworth Group, 2005.
   Google Scholar
• Prabhakaran VC, Saeed P, Esmaeli B, et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol 2007;125:1657–1662.
   Google Scholar
• Bradley DA, Baughman RP, Raymond L, Kaufman AH. Ocular manifestations of sarcoidosis. Semin Respir Crit Care Med 2002;23:543–548.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102:297–301.
   PubMed Web of Science ®Google Scholar
• Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989;72:287–296.
   PubMed Web of Science ®Google Scholar
• Mayers M. Ocular sarcoidosis. Int Ophthalmol Clin 1990;30:257–263.
   PubMedGoogle Scholar
• Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;147:1864–1868.
   Google Scholar
• Salama B, Gicquel JJ, Lenoble P, Dighiero PL. Optic neuropathy in refractory neurosarcoidosis treated with TNF: Alfa antagonist. Can J Ophthalmol 2006;41:766–768.
   PubMed Web of Science ®Google Scholar
• Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000;84:110–6.
   PubMed Web of Science ®Google Scholar
• Dana MR, Merayo-Lioves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 1996;103:1846–53.
   PubMed Web of Science ®Google Scholar
• Bodaghi B, Wechsler B, Du-Boutin LT, Cassoux N, LeHoang P, Piette JC. Uveites chroniques severes: Classification, demarche diagnostique et principes therapeutiques. Rev Med Interne 2003;24:794–802.
   PubMedGoogle Scholar
• Stavrou A, Foster S. Sarcoidosis. In: S. Foster, A. Vitale (eds.). Diagnosis and Treatment of Uveitis, pp. 710–25. Philadelphia, PA: W.B. Saunders, 2002.
   Google Scholar
• Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol 2001;46:209–233.
   PubMed Web of Science ®Google Scholar
• Abad S, Meyssonier V, Allali J, Gouya H, Giraudet AL, Monnet D, et al. Association of peripheral multifocal chorioiditis with sarcoidosis: A study of 37 patients. Arthritis Rheum 2004;51:974–82.
   PubMedGoogle Scholar
• Lardenoye CW, Van der Lelij A, de Loos WS, Treffers WF, Rothova A. Peripheral multifocal chorioretinitis: A distinct clinical entity? Ophthalmology 1997;104:1820–6.
   PubMed Web of Science ®Google Scholar
• Abad S, Seve P, Dhote R, Brezin AP. Uveitis et medicine interne: Strategies diagnostiques et therapeutiques. Rev Med Interne 2009;30:492–500.
   PubMedGoogle Scholar
• Birnbaum AD, Huang W, Sahin O, Tessler HH, Goldstein DA. Ocular sarcoidosis misdiagnosed as primary intraocular lymphoma. Retina 2010;30(2):310–6.
   PubMed Web of Science ®Google Scholar
• Chung YM, Lin YC, Huang DF, Hwang DK, Ho DM. Conjunctival biopsy in sarcoidosis. J Chin Med Assoc 2006;69:472–7.
   PubMedGoogle Scholar
• Yanardag H, Pamuk ON. Lacrimal gland involvement in sarcoidosis: The clinical features of 9 patients. Swiss Med Wkly 2003;388–301.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of Triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139:972–82.
   PubMed Web of Science ®Google Scholar
• Jones NP. Sarcoidosis and uveitis. Ophthalmol Clin North Am 2002;15:319–26.
   PubMedGoogle Scholar
• Hirano Y, Ito T, Nozaki M, et al. Intraocular pressure elevation following Triamcinolone acetonide administration as related to administration routes. Jpn J Ophthalmol 2009;53:519–522.
   PubMed Web of Science ®Google Scholar
• Eljarrat-Binstock E, Peter J, Domb AJ. New techniques for drug delivery to the posterior eye segment. Pharm Res 2010;27:530–543.
   PubMed Web of Science ®Google Scholar
• Pavesio C, Zierhut M, Bairi K, Cornstock TL, Usner DW, Fluocinolone Acetonide Study Group. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology 2010;117:567–575.
   PubMed Web of Science ®Google Scholar
• Kempen JH, Altaweel MM, Holbrock JT, Jabs DA, Sugar EA, Multicenter Uveitis Steroid Treatment Trial Research Group. The multicenter uveitis steroid treatment trial: Rationale, design, and baseline characteristics. Am J Ophthalmol 2010;149:550–561.
   PubMed Web of Science ®Google Scholar
• Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Leki Y. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology 2001;108(6):1140–4.
   PubMed Web of Science ®Google Scholar
• Varron L, Abad S, Kodjikian L, Seve P. Sarcoid uveitis: Diagnostic and therapeutic update. Rev Med Interne 2011;32(2):86–92.
   PubMed Web of Science ®Google Scholar
• Bhat P, Cervantes-Castaneda RA, Doctor PP, Anzaar F, Foster CS. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm 2009;17:185–90.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Pertuiset E. Agents and anti-TNF α and sarcoidose. Rev Med Interne 2010;2(7):475–485.
   Google Scholar
• Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial. Eur Respir J 2008;31:1189–96.
   PubMed Web of Science ®Google Scholar
• Benitez-del-Castillo JM, Martinez-de-la-Casa JM, Pato-Cour E, Mendez-Fernandes R, Lopez-Abad C, Matilla M, et al. Long-term treatment of refractory posterior uveitis with anti-TNF α (infliximab). Eye (Lond) 2005;19:841–5.
   PubMed Web of Science ®Google Scholar